Evaluating the Role of mpMRI in Prostate Cancer Assessment

Francesca V Mertan; Rose Berman; Kathryn Szajek; Peter A Pinto; Peter L Choyke; Baris Turkbey

doi:10.1586/17434440.2016.1134311

Evaluating the Role of mpMRI in Prostate Cancer Assessment

Expert Rev Med Devices. 2016;13(2):129-41. doi: 10.1586/17434440.2016.1134311. Epub 2016 Jan 28.

Authors

Francesca V Mertan¹, Rose Berman¹, Kathryn Szajek^{1

2}, Peter A Pinto³, Peter L Choyke¹, Baris Turkbey¹

Affiliations

¹ a Molecular Imaging Program , NCI, NIH , Bethesda , MD , USA.
² b Department of Science , Mount St. Mary's University , Emmitsburg , MD , USA.
³ c Urologic Oncology Branch , NCI, NIH , Bethesda , MD , USA.

Abstract

Prostate cancer is the most common malignancy among American men. The role of multi-parametric MRI has recently gained more importance in detection of prostate cancer, its targeted biopsy, and focal therapy guidance. In this review, uses of multi-parametric MRI in prostate cancer assessment and treatment are discussed.

Keywords: MRI; PIRADS; biopsy; focal therapy; prostate cancer.

Publication types

Review

MeSH terms

Humans
Imaging, Three-Dimensional
Magnetic Resonance Imaging / methods*
Male
Neoplasm Recurrence, Local / diagnosis
Prostatic Neoplasms / diagnosis*
Reference Standards

Grants and funding

ZIA BC010655-14/Intramural NIH HHS/United States